Tetrodotoxin: Clinical Trials

6 trials of Tetrodotoxin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated. 2 Phase 1, 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Terminated 2
Phase 32Completed 2

Follow Tetrodotoxin: new trials by email Literature Review of Tetrodotoxin trials Research Report on Tetrodotoxin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain
Tetrodotoxin, Placebo - Chemotherapy-induced Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy
Phase 2TerminatedWex Pharmaceuticals Inc.352022-04-192025-02-20
A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects
Tetrodotoxin, Placebos - TQT Study
Phase 1CompletedWex Pharmaceuticals Inc.252018-02-072019-09-10
The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment
Placebo, Tetrodotoxin - Pain, Peripheral Neuropathy
Phase 2TerminatedWex Pharmaceuticals Inc.1252012-07-012018-10-30
Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers
Tetrodotoxin, placebo - Healthy
Phase 1CompletedWex Pharmaceuticals Inc.442011-12-012012-02-08
Tetrodotoxin Open-label Efficacy and Safety Continuation Study
Tetrodotoxin - Pain, Cancer
Phase 3CompletedWex Pharmaceuticals Inc.1132008-07-012012-10-24
Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain
Tetrodotoxin, Placebo - Pain, Cancer
Phase 3CompletedWex Pharmaceuticals Inc.1652008-04-012014-07-09

Conditions studied

Pain (4)  ·  Neoplasms (2)  ·  Neuralgia (1)  ·  Peripheral Nervous System Diseases (1)

Sponsors

Wex Pharmaceuticals Inc. (6)

Countries

United States (4)  ·  Canada (2)

Top investigators

Dr. Neil Hagen, MD, FRCPC (2)  ·  Samuel Goldlust, MD (1)  ·  Walter Korz (1)

Results publications

PMID 28555092